Kinetiq is organized around developing the next generation of enzyme-based treatments for various diseases. Asociated innovations include improving both the upstream molecules and the downstream manufacturing process. Principals of the firm are developing a novel chromatography purification device that is capable of purifying commercial quantities of biological drugs in an easy-to-use and cost-effective way. This "plug-and-play" concept device also utilizes a unique simulation software which takes advantage of computational power in order to make process development much simpler and more effective than the traditional approach. The effort is to decrease the "burden of treatment" on patients - financially, physically, and mentally - especially critical for enzyme-based therapies because patients would normally need to follow such treatments for a lifetime.
